Varian Announces CE Mark for Embozene in Genicular Artery Embolisation, Expanding Treatment for Knee OsteoarthritisBusiness Wire • 09/09/25
Varian Completes Enrollment and Treatment in FAST-02 Clinical Trial of Flash Therapy in Treating Thoracic Bone MetastasesBusiness Wire • 08/25/25
Varian's RapidArc Dynamic Solution Unlocks New Dimensions in Treatment Planning and DeliveryBusiness Wire • 12/18/24
Varian Announces 10-year Transformational Oncology Collaboration with Ballad Health to Bring Advanced Treatment Solutions to Rural CommunitiesBusiness Wire • 09/24/24
Varian Launches HyperSight™ for TrueBeam in Asia Pacific: Boosting Accuracy and Efficiency in Radiotherapy TreatmentGlobeNewsWire • 08/26/24
PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600PRNewsWire • 04/15/21
Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive YearPRNewsWire • 04/12/21
Varian Medical Systems Invests in Bend It Technologies, Ltd., a Company Developing Novel Steerable MicrocathetersPRNewsWire • 03/25/21
CTSI Oncology Solutions, a Varian Company, to Provide Technology-Enabled Services for Radiation Oncology at CHRISTUS HealthPRNewsWire • 02/24/21
Exclusive: EU antitrust regulators to okay Siemens Healthineers' $16.4 billion Varian buy - sourcesReuters • 02/15/21
Varian Installs World's First ProBeam® 360° Proton Therapy System at Penn Medicine Lancaster General HealthPRNewsWire • 02/04/21